‘Pyridoxine treatment in a subgroup of children with pervasive developmental disorders’
2002; Wiley; Volume: 44; Issue: 4 Linguagem: Inglês
10.1111/j.1469-8749.2002.tb00809.x
ISSN1469-8749
AutoresShinichi Kuriyama, Machiko Kamiyama, M Watanabe, Seiko Tamahashi, Itaru Muraguchi, Toru Watanabe, Atsushi Hozawa, Takayoshi Ohkubo, Yoshikazu Nishino, Yoshitaka Tsubono, Ichiro Tsuji, Shigeru Hisamichi,
Tópico(s)Family and Disability Support Research
ResumoDevelopmental Medicine & Child NeurologyVolume 44, Issue 4 p. 284a-286 Free Access 'Pyridoxine treatment in a subgroup of children with pervasive developmental disorders' Shinichi Kuriyama MD, Corresponding Author Shinichi Kuriyama MD Department of Public Health Tohoku University School of Medicine Sendai 980–8575, JapanCorrespondence to: Department of Public Health Tohoku University School of Medicine Sendai 980–8575, JapanSearch for more papers by this authorMachiko Kamiyama ME, Machiko Kamiyama ME Saka General Hospital Shiogama, Miyagi;Search for more papers by this authorMikako Watanabe MD, Mikako Watanabe MD Saka General Hospital Shiogama, Miyagi;Search for more papers by this authorSeiko Tamahashi MD, Seiko Tamahashi MD Saka General Hospital Shiogama, Miyagi;Search for more papers by this authorItaru Muraguchi MD, Itaru Muraguchi MD Saka General Hospital Shiogama, Miyagi;Search for more papers by this authorToru Watanabe BE, Toru Watanabe BE Department of Special Education Miyagi University of Education Sendai, JapanSearch for more papers by this authorAtsushi Hozawa MD, Atsushi Hozawa MD Department of Public Health Tohoku University School of Medicine Sendai 980–8575, JapanSearch for more papers by this authorTakayoshi Ohkubo MD PhD, Takayoshi Ohkubo MD PhD Department of Public Health Tohoku University School of Medicine Sendai 980–8575, JapanSearch for more papers by this authorYoshikazu Nishino MD PhD, Yoshikazu Nishino MD PhD Department of Public Health Tohoku University School of Medicine Sendai 980–8575, JapanSearch for more papers by this authorYoshitaka Tsubono MD PhD, Yoshitaka Tsubono MD PhD Department of Public Health Tohoku University School of Medicine Sendai 980–8575, JapanSearch for more papers by this authorIchiro Tsuji MD PhD, Ichiro Tsuji MD PhD Department of Public Health Tohoku University School of Medicine Sendai 980–8575, JapanSearch for more papers by this authorShigeru Hisamichi MD PhD, Shigeru Hisamichi MD PhD Department of Public Health Tohoku University School of Medicine Sendai 980–8575, JapanSearch for more papers by this author Shinichi Kuriyama MD, Corresponding Author Shinichi Kuriyama MD Department of Public Health Tohoku University School of Medicine Sendai 980–8575, JapanCorrespondence to: Department of Public Health Tohoku University School of Medicine Sendai 980–8575, JapanSearch for more papers by this authorMachiko Kamiyama ME, Machiko Kamiyama ME Saka General Hospital Shiogama, Miyagi;Search for more papers by this authorMikako Watanabe MD, Mikako Watanabe MD Saka General Hospital Shiogama, Miyagi;Search for more papers by this authorSeiko Tamahashi MD, Seiko Tamahashi MD Saka General Hospital Shiogama, Miyagi;Search for more papers by this authorItaru Muraguchi MD, Itaru Muraguchi MD Saka General Hospital Shiogama, Miyagi;Search for more papers by this authorToru Watanabe BE, Toru Watanabe BE Department of Special Education Miyagi University of Education Sendai, JapanSearch for more papers by this authorAtsushi Hozawa MD, Atsushi Hozawa MD Department of Public Health Tohoku University School of Medicine Sendai 980–8575, JapanSearch for more papers by this authorTakayoshi Ohkubo MD PhD, Takayoshi Ohkubo MD PhD Department of Public Health Tohoku University School of Medicine Sendai 980–8575, JapanSearch for more papers by this authorYoshikazu Nishino MD PhD, Yoshikazu Nishino MD PhD Department of Public Health Tohoku University School of Medicine Sendai 980–8575, JapanSearch for more papers by this authorYoshitaka Tsubono MD PhD, Yoshitaka Tsubono MD PhD Department of Public Health Tohoku University School of Medicine Sendai 980–8575, JapanSearch for more papers by this authorIchiro Tsuji MD PhD, Ichiro Tsuji MD PhD Department of Public Health Tohoku University School of Medicine Sendai 980–8575, JapanSearch for more papers by this authorShigeru Hisamichi MD PhD, Shigeru Hisamichi MD PhD Department of Public Health Tohoku University School of Medicine Sendai 980–8575, JapanSearch for more papers by this author First published: 13 February 2007 https://doi.org/10.1111/j.1469-8749.2002.tb00809.xCitations: 20AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Reference 1 American Psychiatric Association. (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington , DC : American Psychiatric Association. 2 Pfeiffer SI, Norton J, Nelson L, Shott S. (1995) Efficacy of vitamin B6 and magnesium in the treatment of autism: a methodology review and summary of outcomes. Journal of Autism and Developmental Disorders 25: 481– 93. 3 Rapin I, Katzman R. (1998) Neurobiology of autism. Annals of Neurology 43: 7– 14. 4 Rapin I. (1997) Autism. New England Journal of Medicine 337: 97– 104. 5 Burd L, Stenehjem A, Franceschini LA, Kerbeshian J. (2000) A 15-year follow-up of a boy with pyridoxine (vitamin B6)-dependent seizures with autism, breath holding, and severe mental retardation. Journal of Child Neurology 15: 763– 5. 6 Baxter P, Griffiths P, Kelly T, Gardner-Medwin D. (1996) Pyridoxine-dependent seizures: demographic, clinical, MRI and psychometric features, and effect of dose on intelligence quotient. Developmental Medicine & Child Neurology 38: 998– 1006. 7 Haenggeli CA, Girardin E, Paunier L. (1991) Pyridoxine-dependent seizures, clinical and therapeutic aspects. European Journal of Pediatrics 150: 452– 5. 8 Bankier A, Turner M, Hopkins IJ. (1983) Pyridoxine dependent seizures: a wider clinical spectrum. Archives of Disease in Childhood 58: 415– 8. 9 Wechsler D. (1992) Wechsler Intelligence Scale for Children-III. New York : Psychological Corporation. 10 Kenkyusho AG, Kenkyusho NS. (1980) Sinban S-M Shaka Seikatsu Noryoku Kensa. Tokyo : Nihon Bunka Kagakusha. (In Japanese). 11 Schaumburg H, Kaplan J, Windebank A, Vick N, Rasmus S, Pleasure D, Brown MJ. (1983) Sensory neuropathy from pyridoxine abuse. New England Journal of Medicine 309: 445– 8. 12 Baxter P. (2001) Pyridoxine-dependent and pyridoxine responsive seizures. Developmental Medicine & Child Neurology 43: 416– 20. Citing Literature Volume44, Issue4April 2002Pages 284a-286 ReferencesRelatedInformation
Referência(s)